The 14th ExEx Symposium addressed the impact of regulatory requirements and clinical constraints on the development strategy for innovative medicines or medical devices, from patient needs to clinical research and market access. Key players such as Swissmedic, experts from large companies and experienced entrepreneurs, as well as associations that promote innovation, shared their experiences. They also addressed the future position of Switzerland in terms of innovation and attractiveness within the international landscape.
The participants came from different areas of development. They benefited from lively discussions and the exchange of ideas and experiences and discovered many new potential contacts.
The event closed with a lively networking apèro.
Leave A Comment